Meiyou Technology
酶有科技
Meiyou Technology (酶有科技) is a startup founded in March 2023 that develops enzymatic DNA synthesis technology, aiming to reduce costs to roughly one-tenth of traditional chemical methods . The company uses AI to optimize enzyme-driven DNA synthesis, and has raised multiple early rounds from Linear Capital, which led both a seed round of nearly $10 million and an angel round of tens of millions of RMB, with additional participation from MiraclePlus and Danen Capital . The funding has been directed toward experimental development, instrument R&D, and team building .
AI-generated — may contain errors, please verify.
Coverage
Taking Gems From Fire — Linear Capital's 2024 Year in Review
2024 is coming to a close. I'd like to borrow the theme from our annual meeting in October to summarize this year: *Taking Gems From Fire* — a fitting description of Linear Capital's work this past year.
线性资本·Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier tech and innovation fund.
线性资本·AI Tech Drives Down Enzymatic DNA Synthesis Costs, Enzymo Technology Raises Tens of Millions in Angel Round Led by Linear Capital
Achieve de novo DNA synthesis at one-tenth the cost of chemical methods.
线性资本·
